Hunan meeting a pharmaceutical machinery co., Ltd. high-tech enterprise in Hunan province, Member of China Association for pharmaceutical equipment industry, standardization Technical Committee member unit of China pharmaceutical machinery, China pharmaceutical machinery industry企业。 the company's registered capital is 20 million Yuan and net assets of $ 80 million. company is located Yu China Central most with vitality of national Changsha economic and technological development zone within, company existing staff more than 200 over, has modernization standard workshop 15,000 square, has United States Haas, world first-class of processing center and the processing device more than 100 over Taiwan sets, company and domestic first-class University in the South University common established of "in the South-the-the meeting a modern drug machine Development Center" is currently the drug industry's only the strongest and jointly operated by Research Center five years national invention patent and utility model patent more than more than 60, development company most new generation of automatic production line for glass bottle big transfusion of non-PVC film and best-selling soft bag infusion production line for nearly three years, high speed glass bottle infusion line market share of more than 70%, non-PVC membrane soft bag infusion market share of more than 50%. the company to launch small needle has a high starting point, Xilin bottle, the first set of card bottle production line, small-volume production equipment technology in China to a new level. the company had step by step, step by step to "pharmaceutical equipment manufacturers of the world's most outstanding" targets close to. and is on schedule to achieve the company's medium-and long-term planning, across the fields of medicine, medical equipment, medicine and engineering materials, production value of over 1 billion high-tech public enterprise group.

first,   personnel
companies enjoying special subsidy of the State Council, the senior member of the Institute of mechanical engineering of China, Chinese Academy of management science special researcher, China National standardization, Member of the Management Committee under the leadership of senior engineer Mr Luo Guoqiang, brought together a group of experienced experts of scientific research and the various types of operations technicians, And with domestic famous universities in the South University jointly set up a "Central South University meeting a modern drug development center " the Centre has 7 senior engineers, 8 professors, associate professors, 12, 26 people. the first-class talents, rich experiences in design and manufacture for the development of enterprises laid a solid foundation.

Second,   technology
meeting a drug infusion products technology research and development capacity in the domestic leading level, at the advanced level in the world, has applied for various types of technology more than 60 patents, first successfully developed the world's first two-in-one high speed non-transfer lines for large infusion production line PVC soft bags, Than similar equipment at home and abroad not only high efficiency, good stability, and each unit of production cost per year fell by almost a million dollars. first successfully developed international production of the fastest 450 bottles/min of high speed glass bottle infusion production line for up to 1 time times faster than similar products at home and abroad, production costs down $ 0.03 per bottle infusion. bottle company in Xilin, oral liquid, water already on the needles with strong technology research and development capacity, and market research and product design work has been completed, these new products were rolled out in November 2007, became the company's new profit growth point.

third,   brand
since its establishment, always adhere to "technological innovation", and product development emphasized stability and high-speed, economical design concept, developed a number of leading new products with independent intellectual property rights. until the end of 2009, total sales of the company production line for soft bag infusion line 56, accounted for more than market 50% market share; glass bottle infusion production line 78, 70% per cent of the market share of the market.undefined

four, and products certification advantage
company holding of Nanning hundred will drug industry soft bag large infusion branch, has domestic most advanced of large infusion line, the company has a products development, and approval, and GMP certification, and production management area of professional talent, can for customer provides samples making, and production practice, and visit learning, facilitate, and can for customer products approval, and GMP certification provides a full set of approval data.